Im, S., Mukai, H., Park, I. H., Masuda, N., Shimizu, C., Kim, S., . . . Toi, M. (2019). Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study. J Glob Oncol.
Chicago Style CitationIm, Seock-Ah, et al. "Palbociclib Plus Letrozole As First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study." J Glob Oncol 2019.
Cita MLAIm, Seock-Ah, et al. "Palbociclib Plus Letrozole As First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study." J Glob Oncol 2019.
Atenció: Aquestes cites poden no estar 100% correctes.